drugset / Trial / NCT07420166

Comparison of Intralesional Triamcinolone Acetonide Treatment With Intralesional Verapamil Hydrochloride in Keloids

NCT07420166

Completed 60 enrolled Muhammad Aamir Latif
RandomizedParallel-groupOpen-labelTreatment

Summary

The paucity of local literature regarding the comparison of intralesional verapamil with intralesional triamcinolone acetonide led this study to be carried out with the objective of comparing the clinical effectiveness of intralesional triamcinolone acetonide and intralesional verapamil hydrochloride in patients with keloids.

Timeline

Start
2025-01-01
Primary completion
2025-06-30
Completion
2025-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Triamcinolone Acetonide Other / unclassified 20 mg/ml Other
Subject Verapamil Other / unclassified 2.5 mg/ml Other

Indications